Thus, the different co-expressed gene networks are compatible with the opposite roles and different underlying mechanisms of RRM2 and RRM2B in different types of cancers, which further stressed the importance of the rationale of the use of RR inhibitors in precision cancer medicine. This evidence concerns the gene RRM2 and cancer.